Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

INTRODUCTION: In the absence of head-to-head trials, this analysis aimed to provide a fair indirect comparison of the efficacy between blinatumomab and inotuzumab ozogamicin (InO), two treatments for adult patients with relapsed or refractory acute lymphoblastic leukemia (R/R ALL) who received no mo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Adv Ther
Autori principali: Song, Jinlin, Ma, Qiufei, Gao, Wei, Cong, Ze, Xie, Jipan, Zimmerman, Zachary, Belton, Laura, Franklin, Janet, Palmer, Stephen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6824351/
https://ncbi.nlm.nih.gov/pubmed/30758745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-0873-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi